99Tc-MDP Treatment for Knee Osteoarthritis
ConditionTreatment Outcome
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40+
SponsorXinhua Hospital, Shanghai Jiao Tong University School of Medicine
About this trial
Osteoarthritis (OA) of knee is the most common form of arthritis in the world1e, and it has received growing attention in the society because of the increase of old age population, disabled people, and medical expenses from this disease. 99Tc-MDP is effective for rheumatoid arthritis. Therefore, the investigators try to investigate the effects of 99Tc-MDP treatment in patients with osteoarthritis of knee as compared with celecoxib.
Eligibility criteria
Qualifiers
Participants with painful osteoarthritis;
The standard uptake value (SUV) of OA related knee greater than 10 on 18F- sodium fluoride bone scan;
Participants voluntarily participate in the trial, and signed the informed consent.
Disqualifiers
Knee joint replacement;
Inflammatory arthritis or joint infection of knee;
Nervous joint disease;
Fracture of joint;
Trial design
Treatments tested in this trial
- 99Tc-MDP
- Celecoxib
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov